Asia Pacific Blood Glucose Test Strip Packaging Market Summary
As per Market Research Future Analysis, the Asia Pacific Blood Glucose Test Strip Packaging Market was valued at USD 0.65 Billion in 2023 and is projected to grow significantly. The market is expected to increase from USD 0.68 Billion in 2024 to USD 1.21 Billion by 2032, reflecting a compound annual growth rate (CAGR) of 8.10% during the forecast period from 2024 to 2032. This growth is driven by advancements in diabetes management technologies and increasing awareness of diabetes care.
Key Market Trends & Highlights
Key trends influencing the Asia Pacific Blood Glucose Test Strip Packaging Market include technological innovations and increased product availability.
- Dario launched a smart blood sugar meter compatible with Apple iPhone 15 in November 2023, enhancing real-time glucose monitoring.
- Zoetis introduced the AlphaTrak 3 blood glucose monitoring device for pets in February 2023, featuring a mobile app for better veterinary communication.
- TruDiagnostic partnered with NADMED in March 2023 to offer a novel NAD+ blood diagnostic test, enhancing diagnostic capabilities.
Market Size & Forecast
| 2023 Market Size | USD 0.65 Billion |
| 2024 Market Size | USD 0.68 Billion |
| 2032 Market Size | USD 1.21 Billion |
Major Players
Roche Diagnostics, Abbott Laboratories, Lifescan, Inc., I-Sens, Inc., Trividia Health, Apex Biotechnology Corporation, Agamatrix Inc, Taidoc Technology Corporation, Universal Biosensors, Beijing Yicheng Electronic Co., Ltd., Sannuo Biosensor Inc, Shanghai Microsense Tm Inc., Acon Laboratories, Inc., Allmedicus, National Diagnostic Products, Hmd Biomedical, Yuwell-Jiangsu Yuyue Medical Equipment & Supply Co., Ltd., Elektronika Kft., B. Braun Melsungen Ag
